Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ATAI Life Sciences N.V. | 62,394 | reported | 05 Nov 2025 | tx 4+719,121 |
| Adaptive Biotechnologies Corp | 62,347 | reported | 04 Mar 2026 | tx 63+311,783−226,968 |
| RECURSION PHARMACEUTICALS, INC. | 44,031 | reported | 18 Jun 2025 | tx 19+761,720−543,750 |
| FATE THERAPEUTICS INC | 40,000 | reported | 06 Jun 2023 | tx 8+107,558−672 |
| ARS Pharmaceuticals, Inc. | 18,000 | reported | 10 Jun 2022 | tx 3+106,251 |
| DENDREON CORP | 15,724 | reported | 19 Jan 2006 | tx 3+48,973 |
| NanoString Technologies Inc | 584 | reported | 18 Apr 2022 | tx 71+96,578−60,716 |
| HilleVax, Inc. | 0 | reported | 17 Sept 2025 | tx 8+971,003−1,139,630 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | GRANT_AWARD | Adaptive Biotechnologies Corp | 15,625 | 0.00 USD | |
| 10 Dec 2025 | SALE | Adaptive Biotechnologies Corp | 22,968 | 16.00 USD | |
| 05 Nov 2025 | GRANT_AWARD | ATAI Life Sciences N.V. | 456,011 | 0.00 USD | deriv |
| 05 Nov 2025 | GRANT_AWARD | ATAI Life Sciences N.V. | 97,716 | 0.00 USD | deriv |
| 05 Nov 2025 | GRANT_AWARD | ATAI Life Sciences N.V. | 62,394 | 0.00 USD | deriv |
| 05 Nov 2025 | GRANT_AWARD | ATAI Life Sciences N.V. | 103,000 | 0.00 USD | deriv |
| 17 Sept 2025 | TENDER | HilleVax, Inc. | 1,101,498 | — | |
| 18 Jun 2025 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 22,016 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 44,031 | 0.00 USD | deriv |
| 12 Mar 2025 | SALE | Adaptive Biotechnologies Corp | 53,000 | 7.59 USD | |
| 04 Mar 2025 | GRANT_AWARD | Adaptive Biotechnologies Corp | 15,394 | 0.00 USD | |
| 04 Mar 2025 | GRANT_AWARD | Adaptive Biotechnologies Corp | 23,726 | 0.00 USD | deriv |
| 11 Feb 2025 | SALE | HilleVax, Inc. | 11,901 | 1.76 USD | |
| 04 Feb 2025 | SALE | HilleVax, Inc. | 14,634 | 1.89 USD | |
| 03 Jun 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 13,097 | 0.00 USD | |
| 03 Jun 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 26,193 | 0.00 USD | deriv |
| 04 Mar 2024 | GRANT_AWARD | Adaptive Biotechnologies Corp | 31,328 | 0.00 USD | |
| 04 Mar 2024 | GRANT_AWARD | Adaptive Biotechnologies Corp | 48,044 | 0.00 USD | deriv |
| 08 Feb 2024 | GRANT_AWARD | HilleVax, Inc. | 174,202 | 0.00 USD | |
| 08 Feb 2024 | SALE | HilleVax, Inc. | 11,597 | 14.93 USD | |
| 08 Feb 2024 | GRANT_AWARD | HilleVax, Inc. | 226,885 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 12,612 | 0.00 USD | |
| 16 Jun 2023 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 25,224 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | FATE THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 06 Mar 2023 | GRANT_AWARD | Adaptive Biotechnologies Corp | 14,775 | 0.00 USD |